Results 101 to 110 of about 1,149,319 (336)
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah +5 more
wiley +1 more source
Objective Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centered care and informing local service pathways and care guidelines or standards.
Sonia Ranelli +8 more
wiley +1 more source
In the present study, green synthesis of silver nanoparticles (AgNPs) were prepared by using Acalypha indica (AI) plant aqueous extract, which is used as a reducing and capping agent. The surface plasma resonance of AI-AgNPs was obtained at 436 nm by the
Vijayalakshmi Sakaray +2 more
doaj +1 more source
Lakes have always held an aesthetic fascination for people; they figure prominently in both art and literature and have even been endowed with spiritual qualities. For example, the nineteenth century American writer Henry D.
Green, John D., Lowe, David J.
core +1 more source
In the context of the worldwide quest for green and sustainable development, there is a growing importance in enhancing the environmental, social, and governance (ESG) performance of manufacturing companies.
Hao Jing, Shiyu Zhang
doaj +1 more source
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla +13 more
wiley +1 more source
Objective Antinuclear antibodies (ANAs) are present at high titers in 2% of the general population, but their clinical significance in individuals without an autoimmune (AI) disease is not known. We tested the hypothesis that the presence of a high ANA titer in non‐AI conditions is associated with disease.
Matthew Chung +7 more
wiley +1 more source
A note on the Freiman and Balog-Szemeredi-Gowers theorems in finite fields
We obtain quantitative versions of the Balog-Szemeredi-Gowers and Freiman theorems in the model case of a finite field geometry F_2^n, improving the previously known bounds in such theorems. For instance, if A is a subset of F_2^n such that |A+A| > K^{-O(
Green, Ben, Tao, Terence
core +1 more source
Background Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti‐collagen II (anti‐Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick +6 more
wiley +1 more source
Objectives Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies. To help patients and providers in the decision‐making process, we developed
Anahita Deboo +19 more
wiley +1 more source

